^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

TMB-L + ARID1A deletion + CDKN2A deletion + CDKN2B deletion + MTAP deletion + PIK3R1 N564D + NBN P81fs*23

i
Other names: PIK3R1, Phosphoinositide-3-Kinase Regulatory Subunit 1, Phosphatidylinositol 3-Kinase 85 KDa Regulatory Subunit Alpha, Phosphoinositide-3-Kinase, Regulatory Subunit 1 (Alpha), Phosphatidylinositol 3-Kinase Regulatory Subunit Alpha, Phosphoinositide-3-Kinase Regulatory Subunit Alpha, PtdIns-3-Kinase Regulatory Subunit Alpha, PI3K Regulatory Subunit Alpha, PI3-Kinase Subunit P85-Alpha, GRB1, Phosphatidylinositol 3-Kinase, Regulatory Subunit, Polypeptide 1 (P85 Alpha), Phosphatidylinositol 3-Kinase-Associated P-85 Alpha, PtdIns-3-Kinase Regulatory Subunit P85-Alpha, PI3-Kinase Regulatory Subunit Alpha, P85-ALPHA, IMD36, AGM7, P85, NBN, Nibrin, Nijmegen Breakage Syndrome 1 (Nibrin), Cell Cycle Regulatory Protein P95, NBS1, NBS, P95, P95 Protein Of The MRE11/RAD50 Complex, Nijmegen Breakage Syndrome Protein 1, AT-V1, AT-V2, ATV, ARID1A, AT-Rich Interaction Domain 1A, SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator Of Chromatin Subfamily F Member 1, AT-Rich Interactive Domain-Containing Protein 1A, AT Rich Interactive Domain 1A (SWI-Like), ARID Domain-Containing Protein 1A, SWI/SNF Complex Protein P270, BRG1-Associated Factor 250a, SWI-Like Protein, Osa Homolog 1, SMARCF1, C1orf4, BAF250, HOSA1, OSA1, AT Rich Interactive Domain 1A (SWI- Like), Chromatin Remodeling Factor P250, BRG1-Associated Factor 250, OSA1 Nuclear Protein, Brain Protein 120, BAF250a, BM029, MRD14, TMB | Tumor Mutational Burden, CDKN2A, Cyclin Dependent Kinase Inhibitor 2A, P14ARF, CDK4I, MTS1, ARF, P16-INK4A, CDKN2, CMM2, INK4, P16, P19, P14, MLM, Cyclin-Dependent Kinase Inhibitor 2A (Melanoma, P16, Inhibits CDK4), Cyclin-Dependent Kinase 4 Inhibitor A, Cyclin-Dependent Kinase Inhibitor 2A, Multiple Tumor Suppressor 1, Alternative Reading Frame, P16INK4a, P16INK4A, P19Arf, INK4a, MTS-1, Cell Cycle Negative Regulator Beta, CDK4 Inhibitor P16-INK4, Tumor Suppressor ARF, P16-INK4a, P16-INK4, P16INK4, P19ARF, INK4A, TP16, CDKN2B, Cyclin Dependent Kinase Inhibitor 2B, Cyclin-Dependent Kinase Inhibitor 2B (P15, Inhibits CDK4), Cyclin-Dependent Kinase 4 Inhibitor B, Multiple Tumor Suppressor, P14-INK4b, P15-INK4b, MTS-2, MTS2, Cyclin-Dependent Kinases 4 And 6 Binding Protein, CDK Inhibitory Protein, P14_CDK Inhibitor, P15 CDK Inhibitor, CDK4B Inhibitor, P14_INK4B, P15_INK4B, P15INK4b, P15INK4B, CDK4I, INK4B, TP15, P15, MTAP, Methylthioadenosine Phosphorylase, S-Methyl-5'-Thioadenosine Phosphorylase, MSAP, 5’-Methylthioadenosine Phosphorylase, MTA Phosphorylase, MTAPase, C86fus, Epididymis Secretory Sperm Binding Protein, Epididymis Luminal Protein 249, MeSAdo Phosphorylase, HEL-249, DMSMFH, DMSFH, LGMBF, BDMF
Entrez ID:
Related biomarkers:
News
Trials